ISO/TC 194
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
86862 | ISO 10993-4:2017/Amd 1:2025 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1 | Standarts spēkā |
64580 | ISO 10993-9:2019 | Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products | Standarts spēkā |
64582 | ISO 10993-16:2017 | Biological evaluation of medical devices — Part 16: Toxicokinetic study design for degradation products and leachables | Standarts spēkā |
75279 | ISO 10993-10:2021 | Biological evaluation of medical devices — Part 10: Tests for skin sensitization | Standarts spēkā |
68426 | ISO 10993-11:2017 | Biological evaluation of medical devices — Part 11: Tests for systemic toxicity | Standarts spēkā |
65052 | ISO/TR 10993-33:2015 | Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3 | Standarts spēkā |
64750 | ISO 10993-18:2020 | Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process | Standarts spēkā |
65918 | ISO/TR 10993-22:2017 | Biological evaluation of medical devices — Part 22: Guidance on nanomaterials | Standarts spēkā |
72766 | ISO 10993-7:2008/Amd 1:2019 | Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals — Amendment 1: Applicability of allowable limits for neonates and infants | Standarts spēkā |
64887 | ISO/TR 37137:2014 | Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants | Standarts spēkā |
Displaying 131-140 of 146 results.